# CORRESP — Aspire Biopharma Holdings, Inc.  (ASBP, ASBPW)  (CIK 0001847345)

> <strong>Aspire Biopharma Holdings, Inc.  (ASBP, ASBPW)  (CIK 0001847345) → SEC staff</strong> · filed 2026-04-13 · ticker ASBP, ASBPW · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001493152-26-016330
- **Form:** CORRESP
- **Filer:** Aspire Biopharma Holdings, Inc.  (ASBP, ASBPW)  (CIK 0001847345)
- **CIK:** 0001847345
- **Ticker:** ASBP, ASBPW
- **Filed:** 2026-04-13
- **SIC industry:** 2834
- **HQ:** Estero, FL

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1847345/000149315226016330/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1847345&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for Aspire Biopharma Holdings, Inc.  (ASBP, ASBPW)  (CIK 0001847345)

- UPLOAD — 2026-02-24 — /comment-letter/0000000000-26-001916
- CORRESP — 2025-09-26 — /comment-letter/0001493152-25-015781
- UPLOAD — 2025-09-24 — /comment-letter/0000000000-25-010426

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Aspire Biopharma Holdings, Inc.  (ASBP, ASBPW)  (CIK 0001847345) (CIK 0001847345), filed 2026-04-13, accession 0001493152-26-016330. Retrieved via MORVS 2026-11-04 from https://api.morvs.ai/comment-letter/0001493152-26-016330.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*